Key result
Current lymphoma patients exhibited autonomic changes compared to cured patients or healthy controls, suggesting autonomic dysfunction in lymphoma is a transient paraneoplastic syndrome.
Why the study?
Is autonomic dysfunction in patients with lymphoma related to chemotherapy or a paraneoplastic syndrome?
Case-Control (n=80)
Is autonomic dysfunction in patients with lymphoma related to chemotherapy or a paraneoplastic syndrome?
Autonomic dysfunction in lymphoma appears to be a transient manifestation of a paraneoplastic syndrome.
Answers are grounded in this paper and cite their sources.
Autonomic dysfunction may be transient in active lymphoma; supports paraneoplastic hypothesis but leaves open chemotherapy role pending prospective studies.
We wanted to determine whether autonomic dysfunction in patients with lymphoma is related to chemotherapy or represent a paraneoplastic syndrome. 40 patients with current or cured Hodgkin or non-Hodgkin lymphoma and 40 healthy controls, matched for age, gender, hypertension and diabetes mellitus underwent autonomic evaluation (Deep Breath, Valsalva Maneuver, Hand Grip, Lying to Standing, Tilt Test). Current patients also suffering from diabetes or hypertension, or still on chemotherapy revealed autonomic changes, while cured or healthy subjects did not. Autonomic dysfunction in lymphoma is a transient manifestation of a paraneoplastic syndrome.
No takes yet. Share an insight, caveat, or question.
Bilora et al. (2010) conducted a case-control in Hodgkin and non-Hodgkin lymphoma (n=80). Current or cured Hodgkin or non-Hodgkin lymphoma vs. Healthy controls was evaluated on Autonomic dysfunction (evaluated via Deep Breath, Valsalva Maneuver, Hand Grip, Lying to Standing, Tilt Test). Current lymphoma patients exhibited autonomic changes compared to cured patients or healthy controls, suggesting autonomic dysfunction in lymphoma is a transient paraneoplastic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: